HIGH-DOSE THERAPY AND AUTOLOGOUS STEM TRANSPLANTATION (ASCT) AS CONSOLIDATION THERAPY DURING FIRST COMPLETE REMISSION (CR) OR PARTIAL REMISSION (PR) IN PATIENTS WITH UNFAVORABLE PROGNOSIS AND ADVANCED-STAGE HODGKINS-DISEASE (HD)
A. Nademanee et al., HIGH-DOSE THERAPY AND AUTOLOGOUS STEM TRANSPLANTATION (ASCT) AS CONSOLIDATION THERAPY DURING FIRST COMPLETE REMISSION (CR) OR PARTIAL REMISSION (PR) IN PATIENTS WITH UNFAVORABLE PROGNOSIS AND ADVANCED-STAGE HODGKINS-DISEASE (HD), Blood, 90(10), 1997, pp. 495-495